ORAL RITLECITINIB AND BREPOCITINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS: CHRONIC THERAPY DATA FROM THE VIBRATO UMBRELLA STUDY

William Sandborn  ¹     Silvio Danese  ²     Jaroslaw Leszczyszyn  ³     Jacek Romatowski  ⁴     Engin Altintas  ⁵     Elena Peeva  ⁶     Michael Vincent  ⁶     Padmalatha Reddy  ⁶     Christopher Banfield  ⁶     Anindita Banerjee  ⁶     Jeremy Gale  ⁶     Kenneth Hung  ^6    
1 University of California San Diego, San Diego, United States
² IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy
³ Melita Medical Center, Wroclaw, Poland
⁴ Provincial Complex Hospital, Bialystok, Poland
⁵ Mersin University, Mersin, Turkey
⁶ Pfizer Inc., Cambridge, United States

Topic
IBD, Nurses, Primary Care

Session
Clinical trials in ulcerative colitis I

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)